Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03414684
Title Carboplatin +/- Nivolumab in Metastatic Triple Negative Breast Cancer
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Dana-Farber Cancer Institute
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
The Stamford Hospital Stamford Connecticut 06904 United States Details
Eastern Maine Medical Center Bangor Maine 04401 United States Details
Beth Israel Deaconess Medical Center Boston Massachusetts 02115 United States Details
Dana-Farber Cancer Institute Boston Massachusetts 02115 United States Details
St. Elizabeth's Medical Center Boston Massachusetts 02135 United States Details
Dana-Farber/Brigham and Women's Cancer Center at Milford Regional Medical Center Milford Massachusetts 01757 United States Details
Dana-Farber/Brigham and Women's Cancer Center in clinical affiliation with South Shore Hospital South Weymouth Massachusetts 02190 United States Details
Dana-Farber/New Hampshire Oncology-Hematology Londonderry New Hampshire 03053 United States Details
Ohio State University Columbus Ohio 43210 United States Details
University of Vermont Medical Center Burlington Vermont 05401 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field